Organization
Cumberland Pharmaceuticals
6 clinical trials
Clinical trial
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous IbuprofenStatus: Completed, Estimated PCD: 2012-12-01
Clinical trial
A Multi-Center, Open-Label, Surveillance Trial To Evaluate The Safety and Efficacy of a Shortened Infusion Time of Intravenous Ibuprofen.Status: Completed, Estimated PCD: 2012-09-01
Clinical trial
A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects With Duchenne Muscular DystrophyStatus: Recruiting, Estimated PCD: 2024-08-31